BIOTA PHARMACEUTIALS INC's ticker is BOTA and the CUSIP is 090694100. A total of 49 filers reported holding BIOTA PHARMACEUTIALS INC in Q1 2016. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2016 | $117,000 | -14.0% | 78,300 | +11.1% | 0.01% | -29.4% |
| Q4 2015 | $136,000 | -6.2% | 70,500 | -5.4% | 0.02% | -10.5% |
| Q3 2015 | $145,000 | +262.5% | 74,500 | +276.3% | 0.02% | +216.7% |
| Q2 2015 | $40,000 | -50.6% | 19,800 | -45.9% | 0.01% | -57.1% |
| Q4 2014 | $81,000 | -37.7% | 36,600 | -30.7% | 0.01% | -30.0% |
| Q3 2014 | $130,000 | -44.9% | 52,800 | -36.9% | 0.02% | -42.9% |
| Q2 2014 | $236,000 | -11.6% | 83,700 | +91.1% | 0.04% | -16.7% |
| Q1 2014 | $267,000 | +256.0% | 43,800 | +142.0% | 0.04% | +223.1% |
| Q4 2013 | $75,000 | 0.0% | 18,100 | 0.0% | 0.01% | -23.5% |
| Q3 2013 | $75,000 | -19.4% | 18,100 | -36.0% | 0.02% | -32.0% |
| Q2 2013 | $93,000 | – | 28,300 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SENZAR ASSET MANAGEMENT, LLC | 1,617,500 | $3,348,000 | 0.58% |
| Broadfin Capital, LLC | 2,611,711 | $5,406,000 | 0.29% |
| RA Capital Management | 807,855 | $1,672,000 | 0.17% |
| TOWERVIEW LLC | 160,000 | $331,000 | 0.16% |
| BVF INC/IL | 350,776 | $726,000 | 0.13% |
| GABELLI & Co INVESTMENT ADVISERS, INC. | 292,807 | $606,000 | 0.09% |
| Koshinski Asset Management, Inc. | 27,200 | $28,180,000 | 0.02% |
| Baker Brothers Advisors | 830,440 | $1,719,000 | 0.02% |
| KNOTT DAVID M | 31,833 | $65,894,000 | 0.01% |
| SHEPHERD KAPLAN KROCHUK, LLC | 26,756 | $55,000 | 0.01% |